Corinne Dot
YOU?
Author Swipe
View article: Continuous versus Intermittent Use of Tear Substitutes in Patients Treated with Anti-VEGF for Neovascular Age-Related Macular Degeneration: The TREDIA Study
Continuous versus Intermittent Use of Tear Substitutes in Patients Treated with Anti-VEGF for Neovascular Age-Related Macular Degeneration: The TREDIA Study Open
NCT06174181.
View article: Efficacy and safety of multiple fluocinolone acetonide implants in diabetic macular oedema: comparison between first and second intravitreal injections
Efficacy and safety of multiple fluocinolone acetonide implants in diabetic macular oedema: comparison between first and second intravitreal injections Open
Purpose To compare the efficacy and safety between a first and a second injection of fluocinolone acetonide implants (FAc-I) in the treatment of diabetic macular oedema (DMO). Methods This retrospective, multicentre cohort study included e…
View article: Consensus‐based recommendations for indications and procedures in retinal laser treatment of Telangiectatic capillaries (<scp>TelCaps</scp>) in vascular macular oedema: A Delphi study
Consensus‐based recommendations for indications and procedures in retinal laser treatment of Telangiectatic capillaries (<span>TelCaps</span>) in vascular macular oedema: A Delphi study Open
Purpose The identification of telangiectatic capillaries (TelCaps) in chronic macular oedema (ME) resistant to conventional intravitreal injections (IVIs) has renewed interest in focal laser treatment. However, the indications and modaliti…
View article: Does intensive anti-VEGF treatment in the first year predict subsequent treatment burden in exudative age-related macular degeneration?
Does intensive anti-VEGF treatment in the first year predict subsequent treatment burden in exudative age-related macular degeneration? Open
Background Anti-VEGF’s have changed the prognosis of exudative age-related macular degeneration (AMD). Ranibizumab and aflibercept have proven their functional efficacy, but their use has revealed in real life a wide variety of patient pro…
View article: Long Intervals between Intravitreal Injections Using a Treat-and-Extend Protocol in a Real-Life Context in AMD: The LIRE Study
Long Intervals between Intravitreal Injections Using a Treat-and-Extend Protocol in a Real-Life Context in AMD: The LIRE Study Open
Introduction: The aim of the study was to assess the outcome of long treat-and-extend (TE) anti-VEGF intravitreal injection (IVI) intervals (≥every 12 weeks [Q12W]) in neovascular age-related macular degeneration (nAMD). The aims of this r…
View article: Management of diabetic macular oedema in France from 2012 to 2018: The nationwide LANDSCAPE study
Management of diabetic macular oedema in France from 2012 to 2018: The nationwide LANDSCAPE study Open
Objective To describe the management of diabetic macular oedema (DME) patients from the entire French population between 2012 and 2018. Methods In this retrospective longitudinal study, we identified adults treated for DME from the French …
View article: Focal Photocoagulation as an Adjunctive Therapy to Reduce the Burden of Intravitreal Injections in Macula Edema Patients, the LyoMAC2 Study
Focal Photocoagulation as an Adjunctive Therapy to Reduce the Burden of Intravitreal Injections in Macula Edema Patients, the LyoMAC2 Study Open
Aim: To assess the efficacy of focal photocoagulation of capillary macroaneurysms (CMA) to reduce the burden of intravitreal injections (IVI) in patients with macular edema (ME). Materials and Methods: Retrospective multicenter study in pa…
View article: Epidemiology of Treated Diabetes Ocular Complications in France 2008–2018—The LANDSCAPE French Nationwide Study
Epidemiology of Treated Diabetes Ocular Complications in France 2008–2018—The LANDSCAPE French Nationwide Study Open
Aim: LANDSCAPE aimed to estimate the annual incidence and prevalence of treated diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) between 2008 and 2018. Methods: This French nationwide observational study used data …
View article: Real-Life Value of the Odysight® Application in At-Home Screening for Exudative Recurrence of Macular Edema
Real-Life Value of the Odysight® Application in At-Home Screening for Exudative Recurrence of Macular Edema Open
Background: The aim of this study was to describe the value of the Odysight® application in addition to a classical follow-up regimen in the detection of exudative recurrences in patients with macular edema. Methods: We conducted an observ…
View article: Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study
Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study Open
Diabetic macular edema (DME) is the main cause of visual impairment in diabetic patients and a chronic disease requiring long-term treatments. The fluocinolone acetonide (FAc) implant has recently been approved to treat DME in patients con…
View article: Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis
Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis Open
Intravitreal injections (IVI) of anti-vascular endothelial growth factor (anti-VEGF) have become the standard of care for age-related macular degeneration (AMD). Although most pivotal trials have used monthly injections, alternative strate…
View article: Macular edema in Cogan-Reese syndrome
Macular edema in Cogan-Reese syndrome Open
We suspect the CME to be inflammatory linked to the pathophysiological hypotheses of the CRS. The CME was successfully treated with topical nonsteroidal anti-inflammatory drugs (NSAID). No consensus is available on its duration. A recurren…
View article: Incidence and Prevalence of Neovascular Age-Related Macular Degeneration in France between 2008 and 2018
Incidence and Prevalence of Neovascular Age-Related Macular Degeneration in France between 2008 and 2018 Open
The LANDSCAPE study provides exhaustive nationwide data on incidence and prevalence of nAMD in France over a 10-year period.
View article: ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema
ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema Open
Real-world ranibizumab treatment improved VA in DME patients, despite fewer injections than recommended.
View article: A prospective multicentre study of intravitreal injections and ocular surface in 219 patients: IVIS study
A prospective multicentre study of intravitreal injections and ocular surface in 219 patients: IVIS study Open
Purpose To assess the impact of intravitreal injections (IVTI) on ocular surface of patients treated with multiple injections. Methods Prospective, tricentric study conducted in patients treated with unilateral IVTI. An asepsis protocol wi…
View article: Visual Acuity Gain Profiles and Anatomical Prognosis Factors in Patients with Drug-Naive Diabetic Macular Edema Treated with Dexamethasone Implant: The NAVEDEX Study
Visual Acuity Gain Profiles and Anatomical Prognosis Factors in Patients with Drug-Naive Diabetic Macular Edema Treated with Dexamethasone Implant: The NAVEDEX Study Open
The purpose of this study is to evaluate the visual acuity (VA) gain profiles between patients with drug-naive diabetic macular edema (DME) treated by dexamethasone implant (DEX-implant) and assess the baseline anatomical and functional fa…
View article: LONG-TERM INCIDENCE AND RISK FACTORS OF OCULAR HYPERTENSION FOLLOWING DEXAMETHASONE-IMPLANT INJECTIONS
LONG-TERM INCIDENCE AND RISK FACTORS OF OCULAR HYPERTENSION FOLLOWING DEXAMETHASONE-IMPLANT INJECTIONS Open
Purpose: To analyze the incidence, risk factors, and time to onset of ocular hypertension (OHT) after intravitreal injections (IVI) of dexamethasone implant and to evaluate the long-term cumulative probability of intraocular pressure eleva…
View article: Variation of choroidal thickness in diabetic macular edema: friend or foe?
Variation of choroidal thickness in diabetic macular edema: friend or foe? Open
International audience
View article: Increased choroidal thickness: a new indicator for monitoring diabetic macular oedema recurrence
Increased choroidal thickness: a new indicator for monitoring diabetic macular oedema recurrence Open
Purpose The aim of this study was to determine whether choroidal thickness (CT) increases at the time of exudative recurrence in diabetic patients with unilateral diabetic macular oedema (DME) treated with intravitreal injections of anti‐V…
View article: Complications of cosmetic iris implants: French series of 87 eyes
Complications of cosmetic iris implants: French series of 87 eyes Open
Purpose: Iris intraocular implants were developed to manage congenital or traumatic iris defects. However, they are also used to change the color of patient eyes. The aim of this retrospective series was to report complications in patients…
View article: Orbital biomechanical changes in Graves’ disease and Thyroid eye disease: application of Corvis ST
Orbital biomechanical changes in Graves’ disease and Thyroid eye disease: application of Corvis ST Open
Purpose: To evaluate the refractive results of Vivinex© toric intraocular lenses after a cataract surgery.Methods: We performed a prospective study including 50 eyes of 25 patients, who had a cataract surgery, operated by a unique surgeon,…